Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

OncoSec submits Device Master File for OMS to FDA

OncoSec Medical Incorporated, which is developing its advanced-stage OMS ElectroOncology therapies for the treatment of solid tumor cancers, announced today the submission of its Device Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its patented OncoSec Medical System (OMS) which consists of a generator and hand-held applicator.

20 Oct 2011

New prosthetic design may not offer same benefits for all knee replacement recipients

Undergoing a knee replacement involves sophisticated medical equipment, but innovative prosthetic design may not offer the same benefits for all knee replacement recipients, Yale School of Medicine researchers report in a perspective article in the October 20 issue of New England Journal of Medicine.

20 Oct 2011

Breakthrough in development of effective therapy against Hendra virus

A team of Federal and university scientists reports a breakthrough in the development of an effective therapy against a deadly virus, Hendra virus. The results of their study, "A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge," will appear in Science Translational Medicine online.

20 Oct 2011

RTS,S vaccine reduces risk of severe malaria in African children

First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.

19 Oct 2011

First results from phase 3 malaria vaccine candidate trial

18 Oct 2011

NanoViricides President completes stock sales program

NanoViricides, Inc. announced that its President, Dr. Anil Diwan, has completed the programmed sale of the NanoViricides stock that he had obtained as a founder.

18 Oct 2011

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Johnson & Johnson today announced sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 4.2%. Domestic sales declined 3.7%.

18 Oct 2011

One in four kindergarten children have difficulty in distinguishing medicine and candy

More than one in four kindergarten children, and one in five teachers, had difficulty distinguishing between medicine and candy in new research conducted by two, now seventh-grade students, who presented their findings on Monday, Oct. 17, at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.

18 Oct 2011

Nanofiber borate glass material may help heal diabetic wounds

Diabetics who suffer from hard-to-heal open wounds may soon have help in the form of a cottony glass material developed at Missouri University of Science and Technology.

15 Oct 2011

Barcodes evolving into a broader class of identifiers in new ways

What if you could trace the history of everything you buy back to its origins? Using your smart phone camera, you could learn what factory made the ingredients in your heart medication, what country grew the corn in your breakfast cereal, or even how to recycle the phone. You could follow the whole life cycle of a product and everyone who handled it along the way to ensure that the medicine you're taking isn't counterfeit and the food you're eating is safe.

14 Oct 2011

BCL11A protein might serve as potential target for sickle cell disease

Flipping a single molecular switch can reverse illness in a model of sickle cell disease, according to a study by researchers at Children's Hospital Boston and Dana-Farber Cancer Institute. When turned off, the switch, a protein called BCL11A, allows the body to manufacture red blood cells with an alternate form of hemoglobin unaffected by the mutation that causes the disease.

14 Oct 2011

WuXi PharmaTech announces acquisition of Abgent

WuXi PharmaTech Inc., a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of Abgent, Inc., a provider of biological research reagent products and services based in Suzhou, China, and San Diego, California.

14 Oct 2011

UCSB receives Dow Chemical grant to create new materials institute

The Dow Chemical Company has awarded UC Santa Barbara up to $15 million to establish a collaborative research initiative that will help shape the future of technology in areas that will benefit society.

12 Oct 2011

Counterfeit drugs risk lives, threaten pharmaceutical industry in India

BBC News examines how counterfeit or substandard medicines are threatening India's fast-growing pharmaceutical industry, writing, "Worth over $12 billion, the industry is expected to grow more than four-fold in the coming decade," but fake drugs in the system are risking both the lives of patients and the reputation of drug makers.

12 Oct 2011

FDA grants Advaxis pre-IND meeting for ADXS-HER2 cancer immunotherapy

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.

12 Oct 2011

GOP candidates prepare for debate; Romney appears to be everyone's target

The Republican presidential hopefuls will face off Tuesday evening in New Hampshire. Even before the event begins, candidates are staking their ground. Texas Gov. Rick Perry went on the offensive, releasing a web video attacking former Mass. Gov. Mitt Romney's health care positions. Meanwhile, the debate will be very important to Herman Cain, who has been climbing in the polls, and Michele Bachmann, who has fallen precipitously.

12 Oct 2011

First Edition: October 11, 2011

Today's headlines include reports about how Mitt Romney taking heat from the other GOP hopefuls, with some of the fire focusing on his Massachusetts health overhaul.

11 Oct 2011

New conference on Innovations in Medical Polymers

MPMN and PlasticsToday.com, both leading news and information providers for the medical device and plastics industry, today announced the launch of a new conference on Innovations in Medical Polymers, providing insights into the latest technological and regulatory developments in the use of polymers in medical devices.

11 Oct 2011

FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers

Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.

11 Oct 2011

Coridon demonstrates 100% protection using DNA HSV-2 vaccine

DNA vaccine development company Coridon Pty Ltd. today announced that it had successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 (HSV-2) vaccine, with outstanding results. The company will now look to progress the program into clinical studies.

10 Oct 2011